IL82298A0 - Anti-dementia agents comprising an adenosine derivative - Google Patents
Anti-dementia agents comprising an adenosine derivativeInfo
- Publication number
- IL82298A0 IL82298A0 IL82298A IL8229887A IL82298A0 IL 82298 A0 IL82298 A0 IL 82298A0 IL 82298 A IL82298 A IL 82298A IL 8229887 A IL8229887 A IL 8229887A IL 82298 A0 IL82298 A0 IL 82298A0
- Authority
- IL
- Israel
- Prior art keywords
- adenosine derivative
- dementia
- adenosine
- dementia agents
- agent
- Prior art date
Links
- 150000003835 adenosine derivatives Chemical class 0.000 title abstract 3
- 229940125682 antidementia agent Drugs 0.000 title abstract 3
- 239000002664 nootropic agent Substances 0.000 title abstract 3
- BIXYYZIIJIXVFW-UUOKFMHZSA-N (2R,3R,4S,5R)-2-(6-amino-2-chloro-9-purinyl)-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound C1=NC=2C(N)=NC(Cl)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O BIXYYZIIJIXVFW-UUOKFMHZSA-N 0.000 abstract 1
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 206010012289 Dementia Diseases 0.000 abstract 1
- 206010039966 Senile dementia Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 125000003917 carbamoyl group Chemical class [H]N([H])C(*)=O 0.000 abstract 1
- MWEQTWJABOLLOS-UHFFFAOYSA-L disodium;[[[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-oxidophosphoryl] hydrogen phosphate;trihydrate Chemical compound O.O.O.[Na+].[Na+].C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP([O-])(=O)OP(O)([O-])=O)C(O)C1O MWEQTWJABOLLOS-UHFFFAOYSA-L 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP61094738A JPH0696534B2 (ja) | 1986-04-25 | 1986-04-25 | 抗痴呆剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL82298A0 true IL82298A0 (en) | 1987-10-30 |
Family
ID=14118453
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL82298A IL82298A0 (en) | 1986-04-25 | 1987-04-22 | Anti-dementia agents comprising an adenosine derivative |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US5023244A (da) |
| EP (1) | EP0253962B1 (da) |
| JP (1) | JPH0696534B2 (da) |
| AT (1) | ATE87209T1 (da) |
| AU (1) | AU610822B2 (da) |
| CA (1) | CA1287298C (da) |
| DE (1) | DE3784977T2 (da) |
| DK (1) | DK169656B1 (da) |
| IE (1) | IE60886B1 (da) |
| IL (1) | IL82298A0 (da) |
| PT (1) | PT84765B (da) |
| ZA (1) | ZA872879B (da) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4843066A (en) * | 1986-11-27 | 1989-06-27 | Nippon Zoki Pharmaceutical Co., Ltd. | Novel adenosine derivatives and pharmaceutical composition containing them as an active ingredient |
| CA2049977A1 (en) * | 1989-03-24 | 1990-09-25 | Hirofumi Kitaoka | Nootropic agent |
| US5206222A (en) * | 1991-05-22 | 1993-04-27 | Vanderbilt University | Methods for the reduction of myocardial reperfusion injury |
| US5432164A (en) * | 1991-10-24 | 1995-07-11 | Novo Nordisk A/S | C2,N6 -disubstituted adenosine derivatives |
| FR2685918B1 (fr) * | 1992-01-08 | 1995-06-23 | Union Pharma Scient Appl | Nouveaux derives de l'adenosine, leurs procedes de preparation, compositions pharmaceutiques les contenant. |
| FR2687678B1 (fr) * | 1992-01-31 | 1995-03-31 | Union Pharma Scient Appl | Nouveaux derives de l'adenosine, leurs procedes de preparation, compositions pharmaceutiques les contenant. |
| DK62692D0 (da) * | 1992-05-14 | 1992-05-14 | Novo Nordisk As | |
| DK62592D0 (da) * | 1992-05-14 | 1992-05-14 | Novo Nordisk As | |
| US5589467A (en) * | 1993-09-17 | 1996-12-31 | Novo Nordisk A/S | 2,5',N6-trisubstituted adenosine derivatives |
| YU44900A (sh) | 1998-01-31 | 2003-01-31 | Glaxo Group Limited | Derivati 2-(purin-9-il)tetrahidrofuran-3,4-diola |
| JP3933870B2 (ja) | 1998-06-23 | 2007-06-20 | グラクソ グループ リミテッド | ２−（プリン−９−イル）−テトラヒドロフラン−３，４−ジオール誘導体 |
| ES2385931T3 (es) | 2000-07-07 | 2012-08-03 | Spectrum Pharmaceuticals, Inc. | MÉTODOS PARA EL TRATAMIENTO DE NEUROPATíA PERIFÉRICA INDUCIDA POR UNA ENFERMEDAD Y AFECCIONES RELACIONADAS. |
| US6759427B2 (en) * | 2001-04-20 | 2004-07-06 | Spectrum Pharmaceuticals, Inc. | Synthesis and methods of use of tetrahydroindolone analogues and derivatives |
| US20030069203A1 (en) * | 2001-06-04 | 2003-04-10 | Lee Steve S. | Method for increasing human performance by reducing muscle fatigue and recovery time through oral administration of adenosine triphosphate |
| US7629329B2 (en) * | 2001-06-04 | 2009-12-08 | Tsi Health Sciences, Inc. | Method for increasing muscle mass and strength through administration of adenosine triphosphate |
| US20030055249A1 (en) * | 2001-07-17 | 2003-03-20 | Fick David B. | Synthesis and methods of use of pyrimidine analogues and derivatives |
| PE20060272A1 (es) | 2004-05-24 | 2006-05-22 | Glaxo Group Ltd | (2r,3r,4s,5r,2'r,3'r,4's,5's)-2,2'-{trans-1,4-ciclohexanodiilbis-[imino(2-{[2-(1-metil-1h-imidazol-4-il)etil]amino}-9h-purin-6,9-diil)]}bis[5-(2-etil-2h-tetrazol-5-il)tetrahidro-3,4-furanodiol] como agonista a2a |
| GB0514809D0 (en) | 2005-07-19 | 2005-08-24 | Glaxo Group Ltd | Compounds |
| IT202300022302A1 (it) * | 2023-10-24 | 2025-04-24 | Univ Degli Studi Di Roma “La Sapienza” | Trattamento di malattie degenerative neuromuscolari |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4224438A (en) * | 1970-07-14 | 1980-09-23 | Boehringer Mannheim Gmbh | Adenosine-5'-carboxylic acid amides |
| US4029884A (en) * | 1971-03-18 | 1977-06-14 | Abbott Laboratories | Adenosine-5'-carboxylic acid amides |
| US3864483A (en) * | 1972-03-22 | 1975-02-04 | Abbott Lab | Adenosine-5{40 -carboxylic acid amides |
| US3992531A (en) * | 1973-12-26 | 1976-11-16 | Abbott Laboratories | 2-Substituted adenosine-5'-carboxylates in the treatment of anginal pain |
| LU73052A1 (da) * | 1975-07-24 | 1977-03-24 | ||
| DE2610985A1 (de) * | 1976-03-16 | 1977-09-29 | Byk Gulden Lomberg Chem Fab | Arzneimittel enthaltend beta-d-1 (6-amino-9h-purin-9-yl)-1-deoxyribofuranuronsaeurederivate |
| LU75374A1 (da) * | 1976-07-13 | 1978-02-08 | ||
| US4167565A (en) * | 1976-11-08 | 1979-09-11 | Abbott Laboratories | Adenosine-5'-carboxamides and method of use |
-
1986
- 1986-04-25 JP JP61094738A patent/JPH0696534B2/ja not_active Expired - Lifetime
-
1987
- 1987-04-21 DE DE8787105843T patent/DE3784977T2/de not_active Expired - Lifetime
- 1987-04-21 AT AT87105843T patent/ATE87209T1/de not_active IP Right Cessation
- 1987-04-21 EP EP87105843A patent/EP0253962B1/en not_active Expired - Lifetime
- 1987-04-22 IL IL82298A patent/IL82298A0/xx not_active IP Right Cessation
- 1987-04-23 ZA ZA872879A patent/ZA872879B/xx unknown
- 1987-04-24 AU AU71946/87A patent/AU610822B2/en not_active Expired
- 1987-04-24 PT PT84765A patent/PT84765B/pt unknown
- 1987-04-24 IE IE106987A patent/IE60886B1/en not_active IP Right Cessation
- 1987-04-24 DK DK209187A patent/DK169656B1/da not_active IP Right Cessation
- 1987-04-24 CA CA000535565A patent/CA1287298C/en not_active Expired - Lifetime
-
1989
- 1989-09-15 US US07/407,696 patent/US5023244A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| PT84765A (en) | 1987-05-01 |
| US5023244A (en) | 1991-06-11 |
| CA1287298C (en) | 1991-08-06 |
| PT84765B (pt) | 1989-12-29 |
| DK209187D0 (da) | 1987-04-24 |
| IE871069L (en) | 1987-10-25 |
| ZA872879B (en) | 1987-11-25 |
| DK169656B1 (da) | 1995-01-09 |
| EP0253962A2 (en) | 1988-01-27 |
| EP0253962A3 (en) | 1988-11-30 |
| DE3784977D1 (de) | 1993-04-29 |
| IE60886B1 (en) | 1994-08-24 |
| AU7194687A (en) | 1987-10-29 |
| EP0253962B1 (en) | 1993-03-24 |
| JPH0696534B2 (ja) | 1994-11-30 |
| JPS62252726A (ja) | 1987-11-04 |
| DK209187A (da) | 1987-10-26 |
| AU610822B2 (en) | 1991-05-30 |
| ATE87209T1 (de) | 1993-04-15 |
| DE3784977T2 (de) | 1993-08-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL82298A0 (en) | Anti-dementia agents comprising an adenosine derivative | |
| HU9008407D0 (en) | Process for the production of purine nucleoside derivatives and medical preparations containing them as active agents | |
| HUT44135A (en) | Herbicide compositions containing triazol-sulfonamide derivatives as active components and process for producing the active components | |
| HUT41957A (en) | Insecticide compositions containing aryl-pyridon derivatives as active agents and process for producing the active agents | |
| HUT49367A (en) | Process for producing aristeromycin/adenosine derivatives and pharmaceutical compositions comprising same as active ingredient | |
| HUT44130A (en) | Herbicide compositions containing thiazolo-triazol-sulfonamide derivatives as active components and process for producing the active components | |
| HUT44131A (en) | Herbicide compositions containing pyrazolo-pyrimidine derivatives as active components and process for producing the active components | |
| HUT46837A (en) | Compositions of insectifuge and acarifuge activity containing alpha, omega-amino-alkohol derivatives as active components and process for producing the active components | |
| HUT48623A (en) | Herbicides comprising 2,5-dihydropyrrole derivatives as active ingredient and process for producing 2,5-dihydropyrrole derivatives | |
| HUT46839A (en) | Herbicide compositions containing phenoxy-phenyl-thiourea-, isothiourea- and carbodiimide derivatives as active components and process for producing the active components | |
| HUT47210A (en) | Insecticide compositions and process for producing benzoyl-urea derivatives as active components | |
| PT84127B (en) | Process for the preparation of 1,2-disubstituted piperidines and of herbicide compositions containing the same | |
| HUT41764A (en) | Herbicide compositions containing 5-amino-4-cyano-1-pyridyl-pyrazole derivatives as active agents and process for producing the active agents | |
| HUT44011A (en) | Herbicide compositions containing n-substituted-3,4,5,6-tetrahydro-phtalimide derivatives as active components and process for producing the active components | |
| NZ233781A (en) | (cyclic)phosphonyl-substituted guanine or adenine derivatives and pharmaceutical compositions | |
| HUT48871A (en) | Herbicidal compositions and process for producing substituted tetrahydrophtalimide derivatives applicable as active ingredient | |
| HUT49850A (en) | Herbicidal compositions comprising pyran derivatives and process for producing the active ingredients | |
| HUT44129A (en) | Herbicide compositions containing 1-aryl-pyrazol derivatives as active components and process for producing 1-aryl-pyrazol derivatives | |
| HUT47792A (en) | Herbicide compositions containing 2,6-substituted-pyridine-carboxylic acid derivatives as active components and process for producing the active components | |
| HUT47902A (en) | Process for producing anilino-phenyl-thiourea-, -isothiourea- and -carbodiimid derivatives and insecticide compositions containing them as active components | |
| HUT43232A (en) | Herbicide compositions containing 2-square bracket-bracket-heterocyclic-oxy-bracket closed-phenoxy-square bracket closed-alkanoyl-bracket-halogeno-alkoxy-bracket closed-anilide derivatives as active agents and process for producing the active agents | |
| HUT53616A (en) | Herbicides comprising n-phenyl tetrahydroindazole derivatives as active ingredient and process for producing the active ingredients | |
| NZ226569A (en) | Process for the two-stage inactivation of viruses using both heat and alkalisation | |
| GR861529B (en) | 1,4-dihydropyridine derivatives used for the treatment of cardiovascular diseases | |
| HUT41961A (en) | Herbicide compositions containing thienyl-sulfonyl-guanidine derivatives as active agents and process for producing the active agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| EXP | Patent expired |